| Primary |
| Hiv Infection |
73.3% |
| Product Used For Unknown Indication |
10.4% |
| Prophylaxis Against Hiv Infection |
3.7% |
| Hypertension |
1.4% |
| Opportunistic Infection Prophylaxis |
1.4% |
| Prophylaxis |
1.1% |
| Neuropathy Peripheral |
1.0% |
| Headache |
0.8% |
| Human Immunodeficiency Virus Transmission |
0.7% |
| Antifungal Prophylaxis |
0.7% |
| Contraception |
0.6% |
| Vitamin Supplementation |
0.6% |
| Anaemia Prophylaxis |
0.6% |
| Depression |
0.6% |
| Productive Cough |
0.6% |
| Acquired Immunodeficiency Syndrome |
0.5% |
| Diabetes Mellitus |
0.5% |
| Pelvic Inflammatory Disease |
0.4% |
| Skin Lesion |
0.4% |
| Hepatitis B |
0.4% |
|
| Abortion Spontaneous |
41.5% |
| Osteoporosis |
11.2% |
| Pregnancy |
6.5% |
| Death |
3.8% |
| Renal Failure |
3.2% |
| Suicide Attempt |
3.2% |
| Stillbirth |
2.9% |
| Premature Baby |
2.6% |
| Pulmonary Tuberculosis |
2.6% |
| Renal Failure Acute |
2.6% |
| Ventricular Septal Defect |
2.6% |
| Anaemia |
2.4% |
| Malaria |
2.4% |
| Hip Fracture |
2.1% |
| Vomiting |
2.1% |
| Gastroenteritis |
1.8% |
| Renal Impairment |
1.8% |
| Respiratory Failure |
1.8% |
| Abortion Induced |
1.5% |
| Maternal Exposure During Pregnancy |
1.5% |
|
| Secondary |
| Hiv Infection |
50.1% |
| Product Used For Unknown Indication |
19.4% |
| Drug Exposure During Pregnancy |
5.5% |
| Drug Use For Unknown Indication |
3.7% |
| Neuropathy Peripheral |
3.0% |
| Human Immunodeficiency Virus Transmission |
2.1% |
| Pelvic Inflammatory Disease |
1.8% |
| Skin Lesion |
1.8% |
| Post-traumatic Pain |
1.6% |
| Vitamin Supplementation |
1.4% |
| Antifungal Prophylaxis |
1.2% |
| Oropharyngeal Candidiasis |
1.2% |
| Vaginal Discharge |
1.2% |
| Antiviral Treatment |
1.0% |
| Prophylaxis |
1.0% |
| Prophylaxis Against Hiv Infection |
1.0% |
| Anaemia Prophylaxis |
0.9% |
| Acne |
0.8% |
| Opportunistic Infection Prophylaxis |
0.8% |
| Skin Papilloma |
0.8% |
|
| Abortion Spontaneous |
16.3% |
| Pregnancy |
8.7% |
| Renal Failure Acute |
7.7% |
| Completed Suicide |
6.7% |
| Drug Exposure During Pregnancy |
5.8% |
| Stillbirth |
5.8% |
| Suicide Attempt |
5.8% |
| Foetal Exposure During Pregnancy |
4.8% |
| Cytolytic Hepatitis |
3.8% |
| Hydrocephalus |
3.8% |
| Muscle Injury |
3.8% |
| Polydactyly |
3.8% |
| Drug Eruption |
2.9% |
| Immune Reconstitution Inflammatory Syndrome |
2.9% |
| Mycobacterium Avium Complex Infection |
2.9% |
| Osteoporosis |
2.9% |
| Psychotic Disorder |
2.9% |
| Renal Impairment |
2.9% |
| Tuberculosis |
2.9% |
| Ultrasound Antenatal Screen Abnormal |
2.9% |
|
| Concomitant |
| Hiv Infection |
43.3% |
| Product Used For Unknown Indication |
28.6% |
| Drug Exposure During Pregnancy |
7.2% |
| Drug Use For Unknown Indication |
4.5% |
| Prophylaxis Against Hiv Infection |
2.6% |
| Diffuse Large B-cell Lymphoma Stage Iv |
1.9% |
| Antifungal Prophylaxis |
1.3% |
| Hepatitis C |
1.3% |
| Prophylaxis |
1.1% |
| Depression |
1.0% |
| Hypertension |
1.0% |
| Disseminated Tuberculosis |
0.8% |
| Herpes Simplex |
0.8% |
| Hiv Test Positive |
0.8% |
| Insomnia |
0.8% |
| Aspergillosis |
0.6% |
| Gastrooesophageal Reflux Disease |
0.6% |
| Hepatitis |
0.6% |
| Pain |
0.6% |
| Pyrexia |
0.6% |
|
| Death |
10.2% |
| Cardiac Arrest |
8.5% |
| Ventricular Septal Defect |
8.5% |
| Abortion Incomplete |
6.8% |
| Abortion Spontaneous |
5.1% |
| Arrhythmia |
5.1% |
| Impetigo |
5.1% |
| Insomnia |
5.1% |
| Premature Labour |
5.1% |
| Sinus Tachycardia |
5.1% |
| Viith Nerve Paralysis |
5.1% |
| Abortion Induced |
3.4% |
| Appendicitis Perforated |
3.4% |
| Chest Pain |
3.4% |
| Drug Interaction |
3.4% |
| Ergot Poisoning |
3.4% |
| General Physical Health Deterioration |
3.4% |
| Hepatitis D |
3.4% |
| Kaposi's Sarcoma |
3.4% |
| Neonatal Asphyxia |
3.4% |
|
| Interacting |
| Hiv Infection |
47.9% |
| Infection |
45.1% |
| Drug Use For Unknown Indication |
5.6% |
| Colitis Ulcerative |
1.4% |
|
| Renal Failure Chronic |
80.0% |
| Mycobacterium Avium Complex Infection |
20.0% |
|
